Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590642 · ClinicalTrials.gov registry record
Augmentation in Tx-resistant OCD: an Open Label Trial
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 30
- Enrollment target
NCT00590642 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 30 participants.
The verdict
NCT00590642 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study examines the use of Acamprosate (Campral(R)) in the treatment of Obsessive Compulsive Disorder (OCD). The treatment of this condition is difficulty and a large percentage of patients fail to respond to medications and have residual symptoms. Such patients are referred to as having treatment resistant OCD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00590642
The ClinicalTrials.gov registry entry for NCT00590642 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00590642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00590642 about?
NCT00590642 is a clinical study titled "Augmentation in Tx-resistant OCD: an Open Label Trial". This study examines the use of Acamprosate (Campral(R)) in the treatment of Obsessive Compulsive Disorder (OCD). The treatment of this condition is difficulty and a large percentage of patients fail to respond to medications and have residual symptoms. Such patients are referred to as having treatme...
What is the current status of trial NCT00590642?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2006-04. Estimated completion is 2009-10.
Who is sponsoring clinical trial NCT00590642?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.